« MAPS-2 documents

MAPS-2 logo  

MAPS-2 trial – Metoclopramide for Avoiding Pneumonia after Stroke 2

Trial documents

MA / 22 / 24

 

MA/22/24

  1. This amendment is to extend the end date of the trial.
  2. The trial will now end 30 April 2027 with recruitment end date between October 2026 - January 2027 depending on when recruitment total has been reached.


Switch to mobile site